Geneva Capital Management LLC Reduces Position in Church & Dwight Co., Inc. (NYSE:CHD)

Geneva Capital Management LLC lessened its holdings in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 276,472 shares of the company's stock after selling 12,382 shares during the period. Geneva Capital Management LLC owned approximately 0.11% of Church & Dwight worth $28,949,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Holocene Advisors LP bought a new stake in shares of Church & Dwight in the 3rd quarter worth about $104,795,000. State Street Corp grew its position in Church & Dwight by 8.0% in the third quarter. State Street Corp now owns 13,116,334 shares of the company's stock worth $1,373,542,000 after acquiring an additional 969,006 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Church & Dwight during the fourth quarter worth approximately $76,565,000. World Investment Advisors LLC bought a new stake in Church & Dwight during the third quarter worth approximately $58,338,000. Finally, Barclays PLC raised its position in Church & Dwight by 63.9% during the third quarter. Barclays PLC now owns 1,106,131 shares of the company's stock valued at $115,832,000 after purchasing an additional 431,257 shares during the period. Hedge funds and other institutional investors own 86.60% of the company's stock.

Church & Dwight Stock Up 0.8 %

Shares of NYSE:CHD traded up $0.89 during trading hours on Monday, hitting $113.22. The company's stock had a trading volume of 2,232,384 shares, compared to its average volume of 1,622,706. The firm's fifty day moving average price is $106.23 and its 200 day moving average price is $105.40. Church & Dwight Co., Inc. has a 52 week low of $96.35 and a 52 week high of $116.46. The company has a market capitalization of $27.85 billion, a price-to-earnings ratio of 47.77, a P/E/G ratio of 3.32 and a beta of 0.57. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24.

Remove Ads

Church & Dwight (NYSE:CHD - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the prior year, the business earned $0.65 earnings per share. As a group, research analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were given a dividend of $0.295 per share. The ex-dividend date was Friday, February 14th. This represents a $1.18 dividend on an annualized basis and a yield of 1.04%. This is an increase from Church & Dwight's previous quarterly dividend of $0.28. Church & Dwight's dividend payout ratio (DPR) is presently 49.79%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CHD. Piper Sandler dropped their target price on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating for the company in a report on Monday, February 3rd. JPMorgan Chase & Co. dropped their price objective on shares of Church & Dwight from $107.00 to $106.00 and set an "underweight" rating for the company in a research note on Friday, February 21st. Truist Financial increased their target price on shares of Church & Dwight from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Monday, February 3rd. Barclays lifted their price target on shares of Church & Dwight from $90.00 to $93.00 and gave the stock an "underweight" rating in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $105.00 price objective on shares of Church & Dwight in a research report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Church & Dwight presently has a consensus rating of "Hold" and an average target price of $111.56.

Insider Buying and Selling at Church & Dwight

In other news, EVP Michael Read bought 1,100 shares of the stock in a transaction on Monday, December 16th. The stock was bought at an average cost of $106.82 per share, for a total transaction of $117,502.00. Following the completion of the purchase, the executive vice president now directly owns 2,505 shares in the company, valued at approximately $267,584.10. The trade was a 78.29 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the company's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $106.11, for a total value of $1,061,100.00. Following the transaction, the director now directly owns 32,500 shares in the company, valued at approximately $3,448,575. The trade was a 23.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,002 shares of company stock worth $1,061,315 over the last quarter. Insiders own 2.00% of the company's stock.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.